Prevention of omalizumab for seasonal allergic rhinoconjunctivitis: a retrospective cohort study
BackgroundAllergic rhinoconjunctivitis (ARC) is an allergic disease that is characterized by conjunctival and nasal symptoms such as edema and congestion of conjunctiva, rhinorrhea, sneezing, and blocked nose.Seasonal ARC (SARC) is usually induced by seasonal allergens and often occurs at specific times during the year.Traditional treatments of SAR